The FDA’s speedy approval of experimental new drugs came to a screeching halt this year

The FDA’s speedy approval of experimental new drugs came to a screeching halt this year

The FDA’s drug center has granted 10 accelerated approvals year to date, a contrast with all-time highs over the last five years. Read More 

Czytaj więcej

We współpracy z: https://fortune.com/2022/12/07/fda-accelerated-pathway-speedy-approval-experimental-drugs-slows-2022-this-year/

Total
0
Shares
Dodaj komentarz

Podobne Wpisy